Immune cell profiling of melanoma metastases from patients treated with TriMixDC-MEL dendritic cell therapy in combination with ipilimumab.

Kelly Schats; Emily A. Van Vré; Isolde Debyser; Arno Vandenbroeck; Yanina Jansen; Teofila Seremet; Koen M. Marien; Erik Fransén; D. Schrijvers; Wim Van Criekinge

doi:10.1200/jco.2017.35.15_suppl.e21030

Immune cell profiling of melanoma metastases from patients treated with TriMixDC-MEL dendritic cell therapy in combination with ipilimumab.

Identifier:nobleid.org/w1/20260515/21DFE679

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/21DFE679.svg?ark=w1%2F20260515%2F21DFE679)](https://nobleid.org/work/w1/20260515/21DFE679)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Immune cell profiling of melanoma metastases from patients treated with TriMixDC-MEL dendritic cell therapy in combination with ipilimumab.

Identifier:nobleid.org/w1/20260515/21DFE679

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/21DFE679.svg?ark=w1%2F20260515%2F21DFE679)](https://nobleid.org/work/w1/20260515/21DFE679)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work